ArticleScientific reports2021

Higher CD4/CD8 ratio of pleural effusion predicts better survival for lung cancer patients receiving immune checkpoint inhibitors.

Po-Hsin Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.